Cambridge House Royal Smoked Salmon Sliced Side Products are packaged in Reduced Oxygen Package (ROP). Product is priced per pound.
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2774-2015.
The Santa Barbara Smokehouse, Inc. is recalling fresh and frozen cold smoked salmon due to potential Listeria Monocytogenes contamination.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2774-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact The Santa Barbara Smokehouse, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2774-2015.
The Santa Barbara Smokehouse, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
The Santa Barbara Smokehouse, Inc. Recall FAQ
The Santa Barbara Smokehouse, Inc. is the subject of a seafood safety report: Cambridge House Royal Smoked Salmon Sliced Side Products are packaged in Reduced Oxygen Package (ROP). Product is priced per pound.. The notice was published on June 4, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 250,000 units are potentially affected.